Alkermes (ALKS) Current Assets (2011 - 2026)
Alkermes (ALKS) recorded Current Assets of $1.52 billion in Q2 2026, down 6.9% from $1.64 billion a year earlier but up 12.1% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Alkermes reported Current Assets of $1.93 billion, up 36.3% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of 11.7% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $1.42 billion in FY2024 (-4.7%), $1.49 billion in FY2023 (+31.4%), $1.13 billion in FY2022 (+6.4%) and $1.06 billion in FY2021 (-4.4%).
- Quarterly Current Assets has ranged from $1.01 billion in Q1 2022 to $1.93 billion in Q4 2025 over the past five years.
- On a year-over-year basis, Current Assets rose in five of the last eight quarters, with growth averaging 5.2%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 39.0% in Q3 2023, against a decline of 8.1% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.36 billion (Q1 2026), $1.93 billion (Q4 2025) and $1.74 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn | 1.52 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.52 Bn |
| Mar 31, 2026 | 1.36 Bn |
| Dec 31, 2025 | 1.93 Bn |
| Sep 30, 2025 | 1.74 Bn |
| Jun 30, 2025 | 1.64 Bn |
| Mar 31, 2025 | 1.48 Bn |
| Dec 31, 2024 | 1.42 Bn |
| Sep 30, 2024 | 1.56 Bn |
| Jun 30, 2024 | 1.54 Bn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.49 Bn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.11 Bn |
| Dec 31, 2022 | 1.13 Bn |
| Sep 30, 2022 | 1.05 Bn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 1.01 Bn |
| Dec 31, 2021 | 1.06 Bn |
| Sep 30, 2021 | 1.05 Bn |
API Access
Alkermes Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();